| camera type eye development | GO:0043010 | 266 | 0.374 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.239 | |
| skeletal system development | GO:0001501 | 356 | 0.226 | |
| stem cell differentiation | GO:0048863 | 268 | 0.225 | |
| muscle tissue development | GO:0060537 | 308 | 0.193 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.187 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.186 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.150 | |
| axonogenesis | GO:0007409 | 274 | 0.138 | |
| actin cytoskeleton organization | GO:0030036 | 220 | 0.134 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.131 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.127 | |
| regulation of secretion | GO:0051046 | 274 | 0.126 | |
| circulatory system process | GO:0003013 | 197 | 0.124 | |
| epithelial tube morphogenesis | GO:0060562 | 303 | 0.123 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.122 | |
| forebrain development | GO:0030900 | 302 | 0.119 | |
| gland development | GO:0048732 | 330 | 0.118 | |
| hair follicle development | GO:0001942 | 85 | 0.113 | |
| ossification | GO:0001503 | 216 | 0.110 | |
| muscle system process | GO:0003012 | 141 | 0.108 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.108 | |
| sensory organ morphogenesis | GO:0090596 | 242 | 0.104 | |
| tissue remodeling | GO:0048771 | 102 | 0.099 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.098 | |
| central nervous system neuron differentiation | GO:0021953 | 162 | 0.098 | |
| muscle contraction | GO:0006936 | 101 | 0.096 | |
| limbic system development | GO:0021761 | 72 | 0.096 | |
| endocrine system development | GO:0035270 | 98 | 0.096 | |
| hexose metabolic process | GO:0019318 | 98 | 0.095 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.094 | |
| regulation of ion transport | GO:0043269 | 215 | 0.091 | |
| amine metabolic process | GO:0009308 | 45 | 0.091 | |
| forebrain cell migration | GO:0021885 | 58 | 0.088 | |
| regulation of metal ion transport | GO:0010959 | 106 | 0.087 | |
| regulation of anatomical structure size | GO:0090066 | 178 | 0.086 | |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.085 | |
| hair cycle | GO:0042633 | 90 | 0.081 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.080 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.080 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.078 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.077 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.076 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.075 | |
| ameboidal type cell migration | GO:0001667 | 128 | 0.074 | |
| regulation of system process | GO:0044057 | 200 | 0.073 | |
| blood circulation | GO:0008015 | 195 | 0.070 | |
| fat cell differentiation | GO:0045444 | 160 | 0.070 | |
| regulation of cell motility | GO:2000145 | 236 | 0.068 | |
| placenta development | GO:0001890 | 140 | 0.068 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.068 | |
| muscle cell development | GO:0055001 | 133 | 0.068 | |
| skin morphogenesis | GO:0043589 | 38 | 0.067 | |
| neuron projection guidance | GO:0097485 | 141 | 0.066 | |
| carbon catabolite repression of transcription from rna polymerase ii promoter | GO:0000437 | 1 | 0.065 | |
| positive regulation of voltage gated calcium channel activity | GO:1901387 | 2 | 0.064 | |
| cell fate commitment | GO:0045165 | 210 | 0.064 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.064 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.064 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.064 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.063 | |
| formation of primary germ layer | GO:0001704 | 77 | 0.063 | |
| response to acid chemical | GO:0001101 | 111 | 0.063 | |
| prostate gland stromal morphogenesis | GO:0060741 | 2 | 0.063 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.062 | |
| lens development in camera type eye | GO:0002088 | 62 | 0.062 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.062 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.062 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.061 | |
| odontogenesis | GO:0042476 | 78 | 0.061 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.060 | |
| regulation of ossification | GO:0030278 | 112 | 0.060 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.060 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.060 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.059 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.059 | |
| bmp signaling pathway | GO:0030509 | 93 | 0.059 | |
| rhythmic process | GO:0048511 | 174 | 0.059 | |
| limb morphogenesis | GO:0035108 | 149 | 0.058 | |
| positive regulation of angiogenesis | GO:0045766 | 46 | 0.057 | |
| chondrocyte differentiation | GO:0002062 | 72 | 0.057 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.056 | |
| striated muscle cell development | GO:0055002 | 125 | 0.056 | |
| regulation of cell migration | GO:0030334 | 219 | 0.056 | |
| regulation of protein transport | GO:0051223 | 163 | 0.055 | |
| transmembrane receptor protein serine threonine kinase signaling pathway | GO:0007178 | 194 | 0.055 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.054 | |
| developmental growth involved in morphogenesis | GO:0060560 | 138 | 0.054 | |
| mammillary body development | GO:0021767 | 1 | 0.054 | |
| developmental maturation | GO:0021700 | 193 | 0.053 | |
| paraxial mesodermal cell differentiation | GO:0048342 | 2 | 0.053 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.053 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.053 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.053 | |
| regulation of systemic arterial blood pressure mediated by a chemical signal | GO:0003044 | 33 | 0.052 | |
| t cell activation | GO:0042110 | 289 | 0.052 | |
| paraxial mesodermal cell fate commitment | GO:0048343 | 2 | 0.051 | |
| chemotaxis | GO:0006935 | 247 | 0.051 | |
| gliogenesis | GO:0042063 | 141 | 0.051 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.051 | |
| adenylate cyclase inhibiting serotonin receptor signaling pathway | GO:0007198 | 1 | 0.050 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.050 | |
| response to inorganic substance | GO:0010035 | 96 | 0.050 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.050 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.050 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.049 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.049 | |
| mesoderm formation | GO:0001707 | 62 | 0.049 | |
| thyroid stimulating hormone secreting cell differentiation | GO:0060129 | 4 | 0.049 | |
| wnt signaling pathway | GO:0016055 | 188 | 0.048 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.048 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.048 | |
| biomineral tissue development | GO:0031214 | 64 | 0.048 | |
| telencephalon development | GO:0021537 | 186 | 0.047 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.047 | |
| atrial ventricular junction remodeling | GO:0003294 | 2 | 0.047 | |
| regulation of neural precursor cell proliferation | GO:2000177 | 70 | 0.046 | |
| response to growth factor | GO:0070848 | 198 | 0.046 | |
| hypophysis morphogenesis | GO:0048850 | 3 | 0.046 | |
| regulation of systemic arterial blood pressure | GO:0003073 | 61 | 0.046 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.046 | |
| response to amino acid | GO:0043200 | 37 | 0.045 | |
| cytokine production | GO:0001816 | 319 | 0.045 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.043 | |
| positive regulation of transcription via serum response element binding | GO:0010735 | 1 | 0.043 | |
| regulation of action potential | GO:0098900 | 4 | 0.043 | |
| developmental induction | GO:0031128 | 34 | 0.043 | |
| membrane organization | GO:0061024 | 245 | 0.042 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.042 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.042 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.042 | |
| response to radiation | GO:0009314 | 165 | 0.042 | |
| muscle fiber development | GO:0048747 | 76 | 0.041 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.041 | |
| kidney development | GO:0001822 | 213 | 0.041 | |
| hormone secretion | GO:0046879 | 128 | 0.040 | |
| neural precursor cell proliferation | GO:0061351 | 121 | 0.040 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.040 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.040 | |
| exocrine system development | GO:0035272 | 45 | 0.040 | |
| action potential | GO:0001508 | 78 | 0.039 | |
| urogenital system development | GO:0001655 | 261 | 0.039 | |
| morphogenesis of a branching epithelium | GO:0061138 | 193 | 0.039 | |
| regulation of ventricular cardiac muscle cell membrane depolarization | GO:0060373 | 2 | 0.039 | |
| telencephalon cell migration | GO:0022029 | 55 | 0.039 | |
| ventral spinal cord interneuron fate commitment | GO:0060579 | 14 | 0.039 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.038 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.038 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.038 | |
| endocrine process | GO:0050886 | 39 | 0.038 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.038 | |
| somatotropin secreting cell differentiation | GO:0060126 | 4 | 0.038 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.038 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.038 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.037 | |
| mapk cascade | GO:0000165 | 281 | 0.037 | |
| pancreatic pp cell fate commitment | GO:0003329 | 2 | 0.037 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.037 | |
| neural tube development | GO:0021915 | 160 | 0.037 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.037 | |
| response to extracellular stimulus | GO:0009991 | 127 | 0.037 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.037 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.037 | |
| renal system process | GO:0003014 | 48 | 0.037 | |
| regulation of protein localization | GO:0032880 | 231 | 0.037 | |
| cell growth | GO:0016049 | 130 | 0.036 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.036 | |
| ectoderm formation | GO:0001705 | 3 | 0.036 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.036 | |
| epidermis development | GO:0008544 | 187 | 0.036 | |
| stem cell development | GO:0048864 | 219 | 0.036 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.036 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.035 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.035 | |
| regulation of cartilage development | GO:0061035 | 44 | 0.035 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.035 | |
| neuronal action potential | GO:0019228 | 54 | 0.035 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.034 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.034 | |
| appendage morphogenesis | GO:0035107 | 149 | 0.034 | |
| labyrinthine layer development | GO:0060711 | 49 | 0.034 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.034 | |
| forebrain neuron differentiation | GO:0021879 | 52 | 0.034 | |
| digestive tract development | GO:0048565 | 190 | 0.033 | |
| mammary gland duct morphogenesis | GO:0060603 | 38 | 0.033 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.033 | |
| vascular process in circulatory system | GO:0003018 | 62 | 0.033 | |
| positive regulation of behavior | GO:0048520 | 40 | 0.033 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.033 | |
| response to nutrient levels | GO:0031667 | 109 | 0.032 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.032 | |
| embryonic placenta development | GO:0001892 | 98 | 0.032 | |
| regulation of bone mineralization | GO:0030500 | 31 | 0.032 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.032 | |
| bone mineralization | GO:0030282 | 54 | 0.032 | |
| respiratory system development | GO:0060541 | 190 | 0.032 | |
| epidermis morphogenesis | GO:0048730 | 33 | 0.032 | |
| cellular homeostasis | GO:0019725 | 240 | 0.032 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.032 | |
| blood vessel remodeling | GO:0001974 | 33 | 0.032 | |
| embryonic organ morphogenesis | GO:0048562 | 276 | 0.032 | |
| transmembrane receptor protein tyrosine kinase signaling pathway | GO:0007169 | 247 | 0.031 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.031 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.031 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.031 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.031 | |
| regulation of blood vessel size | GO:0050880 | 56 | 0.030 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.030 | |
| regulation of neuron projection development | GO:0010975 | 169 | 0.030 | |
| nephron development | GO:0072006 | 109 | 0.030 | |
| regulation of protein kinase activity | GO:0045859 | 232 | 0.030 | |
| mesoderm morphogenesis | GO:0048332 | 64 | 0.030 | |
| positive regulation of apoptotic process | GO:0043065 | 217 | 0.030 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.030 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.029 | |
| regulation of renin secretion into blood stream | GO:1900133 | 4 | 0.029 | |
| neuron death | GO:0070997 | 154 | 0.029 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.029 | |
| regulation of cellular carbohydrate metabolic process | GO:0010675 | 75 | 0.029 | |
| cerebral cortex gabaergic interneuron differentiation | GO:0021892 | 9 | 0.029 | |
| subpallium neuron fate commitment | GO:0060163 | 2 | 0.029 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.029 | |
| cell fate specification | GO:0001708 | 72 | 0.029 | |
| negative regulation of wnt signaling pathway | GO:0030178 | 73 | 0.028 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.028 | |
| foramen ovale closure | GO:0035922 | 1 | 0.028 | |
| positive regulation of cell adhesion | GO:0045785 | 80 | 0.028 | |
| b cell activation | GO:0042113 | 161 | 0.028 | |
| embryonic skeletal system morphogenesis | GO:0048704 | 91 | 0.028 | |
| amide transport | GO:0042886 | 138 | 0.028 | |
| negative regulation of cell activation | GO:0050866 | 111 | 0.028 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.028 | |
| tissue migration | GO:0090130 | 68 | 0.027 | |
| endothelial cell migration | GO:0043542 | 44 | 0.027 | |
| positive regulation of kidney smooth muscle cell differentiation | GO:2000358 | 1 | 0.027 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.027 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.027 | |
| appendage development | GO:0048736 | 166 | 0.027 | |
| retina development in camera type eye | GO:0060041 | 119 | 0.027 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.027 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.027 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.027 | |
| muscle cell proliferation | GO:0033002 | 52 | 0.027 | |
| spinal cord oligodendrocyte cell fate specification | GO:0021530 | 3 | 0.027 | |
| myotube differentiation | GO:0014902 | 105 | 0.027 | |
| positive regulation of stem cell proliferation | GO:2000648 | 59 | 0.027 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.026 | |
| branching morphogenesis of an epithelial tube | GO:0048754 | 159 | 0.026 | |
| forebrain generation of neurons | GO:0021872 | 63 | 0.026 | |
| nephron epithelium development | GO:0072009 | 92 | 0.026 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.026 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.026 | |
| regulation of neuron death | GO:1901214 | 134 | 0.026 | |
| ion transmembrane transport | GO:0034220 | 361 | 0.026 | |
| cation homeostasis | GO:0055080 | 212 | 0.026 | |
| cell communication by chemical coupling | GO:0010643 | 2 | 0.026 | |
| detection of monosaccharide stimulus | GO:0034287 | 1 | 0.025 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.025 | |
| regulation of transcription from rna polymerase ii promoter involved in ventral spinal cord interneuron specification | GO:0021913 | 4 | 0.025 | |
| organ growth | GO:0035265 | 117 | 0.025 | |
| heart morphogenesis | GO:0003007 | 178 | 0.025 | |
| regulation of transmembrane transport | GO:0034762 | 128 | 0.025 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.025 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.024 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.024 | |
| cartilage development | GO:0051216 | 140 | 0.024 | |
| renal system development | GO:0072001 | 225 | 0.024 | |
| cell maturation | GO:0048469 | 127 | 0.024 | |
| artery development | GO:0060840 | 53 | 0.024 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.024 | |
| regulation of lymphocyte proliferation | GO:0050670 | 117 | 0.024 | |
| cyclic nucleotide metabolic process | GO:0009187 | 59 | 0.024 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.024 | |
| organ induction | GO:0001759 | 21 | 0.024 | |
| detection of stimulus | GO:0051606 | 84 | 0.024 | |
| olfactory bulb development | GO:0021772 | 30 | 0.024 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.024 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.024 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.024 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.024 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.024 | |
| inflammatory response | GO:0006954 | 244 | 0.024 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.023 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.023 | |
| canonical wnt signaling pathway | GO:0060070 | 130 | 0.023 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.023 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.023 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.023 | |
| multicellular organismal water homeostasis | GO:0050891 | 23 | 0.023 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.023 | |
| mesoderm development | GO:0007498 | 100 | 0.023 | |
| negative regulation of camp metabolic process | GO:0030815 | 5 | 0.023 | |
| neuron migration | GO:0001764 | 122 | 0.023 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.023 | |
| positive regulation of rna polymerase ii transcriptional preinitiation complex assembly | GO:0045899 | 2 | 0.022 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.022 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.022 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.022 | |
| multicellular organism growth | GO:0035264 | 161 | 0.022 | |
| regulation of hormone secretion | GO:0046883 | 88 | 0.022 | |
| spinal cord oligodendrocyte cell differentiation | GO:0021529 | 3 | 0.022 | |
| t cell differentiation | GO:0030217 | 174 | 0.022 | |
| atrioventricular node cell differentiation | GO:0060922 | 2 | 0.022 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.022 | |
| second messenger mediated signaling | GO:0019932 | 73 | 0.022 | |
| adenylate cyclase inhibiting g protein coupled acetylcholine receptor signaling pathway | GO:0007197 | 1 | 0.022 | |
| cerebral cortex neuron differentiation | GO:0021895 | 19 | 0.021 | |
| regulation of muscle tissue development | GO:1901861 | 97 | 0.021 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.021 | |
| cellular response to external stimulus | GO:0071496 | 88 | 0.021 | |
| peptide secretion | GO:0002790 | 114 | 0.021 | |
| chromatin organization | GO:0006325 | 206 | 0.021 | |
| motor neuron axon guidance | GO:0008045 | 26 | 0.021 | |
| smoothened signaling pathway | GO:0007224 | 105 | 0.021 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.021 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.021 | |
| atrioventricular node cell development | GO:0060928 | 2 | 0.021 | |
| positive regulation of neural precursor cell proliferation | GO:2000179 | 42 | 0.021 | |
| regulation of voltage gated calcium channel activity | GO:1901385 | 4 | 0.021 | |
| regulation of blood circulation | GO:1903522 | 93 | 0.021 | |
| regulation of organ growth | GO:0046620 | 61 | 0.021 | |
| cellular response to extracellular stimulus | GO:0031668 | 81 | 0.021 | |
| purkinje myocyte development | GO:0003165 | 1 | 0.021 | |
| angiogenesis | GO:0001525 | 201 | 0.021 | |
| molting cycle | GO:0042303 | 90 | 0.021 | |
| connective tissue development | GO:0061448 | 179 | 0.021 | |
| sensory perception of chemical stimulus | GO:0007606 | 51 | 0.020 | |
| establishment or maintenance of cell polarity | GO:0007163 | 86 | 0.020 | |
| digestive system development | GO:0055123 | 200 | 0.020 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.020 | |
| regulation of cell adhesion | GO:0030155 | 154 | 0.020 | |
| negative regulation of blood vessel morphogenesis | GO:2000181 | 25 | 0.020 | |
| av node cell to bundle of his cell communication | GO:0086067 | 2 | 0.020 | |
| cell adhesion | GO:0007155 | 329 | 0.020 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.020 | |
| stem cell maintenance | GO:0019827 | 130 | 0.020 | |
| somatic stem cell maintenance | GO:0035019 | 47 | 0.020 | |
| mesonephric epithelium development | GO:0072163 | 94 | 0.020 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.020 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.020 | |
| lung alveolus development | GO:0048286 | 45 | 0.020 | |
| myotube cell development | GO:0014904 | 60 | 0.020 | |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.019 | |
| spinal cord development | GO:0021510 | 81 | 0.019 | |
| negative regulation of adenylate cyclase activity | GO:0007194 | 1 | 0.019 | |
| cardiac pacemaker cell fate commitment | GO:0060927 | 1 | 0.019 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.019 | |
| regulation of vasculature development | GO:1901342 | 88 | 0.019 | |
| circadian rhythm | GO:0007623 | 114 | 0.019 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.019 | |
| conditioned taste aversion | GO:0001661 | 4 | 0.019 | |
| neuron projection extension | GO:1990138 | 64 | 0.019 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.019 | |
| thymus development | GO:0048538 | 41 | 0.019 | |
| locomotory behavior | GO:0007626 | 195 | 0.019 | |
| regulation of transmembrane receptor protein serine threonine kinase signaling pathway | GO:0090092 | 112 | 0.019 | |
| sensory perception | GO:0007600 | 245 | 0.019 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.019 | |
| purkinje myocyte differentiation | GO:0003168 | 1 | 0.019 | |
| divalent inorganic cation transport | GO:0072511 | 178 | 0.019 | |
| carbon catabolite activation of transcription from rna polymerase ii promoter | GO:0000436 | 4 | 0.019 | |
| corticotropin releasing hormone secretion | GO:0043396 | 2 | 0.018 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.018 | |
| neurohypophysis development | GO:0021985 | 2 | 0.018 | |
| embryonic skeletal system development | GO:0048706 | 120 | 0.018 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.018 | |
| negative regulation of cell migration | GO:0030336 | 59 | 0.018 | |
| histone modification | GO:0016570 | 159 | 0.018 | |
| extracellular structure organization | GO:0043062 | 148 | 0.018 | |
| cellular response to starvation | GO:0009267 | 57 | 0.018 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.018 | |
| mammillary axonal complex development | GO:0061373 | 1 | 0.018 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.018 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.018 | |
| metanephros development | GO:0001656 | 79 | 0.018 | |
| skeletal muscle satellite cell commitment | GO:0014813 | 1 | 0.017 | |
| oxidation reduction process | GO:0055114 | 342 | 0.017 | |
| inferior colliculus development | GO:0061379 | 2 | 0.017 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.017 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.017 | |
| glial cell differentiation | GO:0010001 | 131 | 0.017 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.017 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.017 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.017 | |
| spinal cord dorsal ventral patterning | GO:0021513 | 23 | 0.017 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.017 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.017 | |
| regulation of cell growth | GO:0001558 | 91 | 0.017 | |
| regulation of neuroblast proliferation | GO:1902692 | 27 | 0.017 | |
| regulation of feeding behavior | GO:0060259 | 3 | 0.017 | |
| protein localization to membrane | GO:0072657 | 108 | 0.017 | |
| regulation of tube size | GO:0035150 | 57 | 0.017 | |
| kidney vasculature development | GO:0061440 | 15 | 0.017 | |
| ventricular septum morphogenesis | GO:0060412 | 27 | 0.017 | |
| metanephric capsule specification | GO:0072267 | 1 | 0.017 | |
| adaptive immune response | GO:0002250 | 155 | 0.017 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.017 | |
| type b pancreatic cell fate commitment | GO:0003327 | 1 | 0.017 | |
| pancreatic pp cell differentiation | GO:0003312 | 2 | 0.017 | |
| atrioventricular node cell fate commitment | GO:0060929 | 1 | 0.017 | |
| mineralocorticoid biosynthetic process | GO:0006705 | 1 | 0.017 | |
| central nervous system vasculogenesis | GO:0022009 | 3 | 0.016 | |
| regulation of sodium ion transport | GO:0002028 | 29 | 0.016 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.016 | |
| adult behavior | GO:0030534 | 135 | 0.016 | |
| learning or memory | GO:0007611 | 148 | 0.016 | |
| cellular response to hormone stimulus | GO:0032870 | 150 | 0.016 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.016 | |
| wound healing | GO:0042060 | 157 | 0.016 | |
| bone development | GO:0060348 | 120 | 0.016 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.016 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.016 | |
| gastrulation | GO:0007369 | 116 | 0.016 | |
| diencephalon development | GO:0021536 | 63 | 0.016 | |
| regulation of ras protein signal transduction | GO:0046578 | 114 | 0.016 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.016 | |
| sensory perception of sound | GO:0007605 | 97 | 0.016 | |
| regulation of smooth muscle contraction | GO:0006940 | 22 | 0.016 | |
| ovulation cycle | GO:0042698 | 59 | 0.016 | |
| carbohydrate derivative biosynthetic process | GO:1901137 | 183 | 0.016 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.016 | |
| bone morphogenesis | GO:0060349 | 78 | 0.016 | |
| pallium development | GO:0021543 | 120 | 0.016 | |
| endoderm development | GO:0007492 | 45 | 0.016 | |
| paramesonephric duct development | GO:0061205 | 3 | 0.016 | |
| peptide transport | GO:0015833 | 133 | 0.015 | |
| ear morphogenesis | GO:0042471 | 118 | 0.015 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.015 | |
| leukocyte migration | GO:0050900 | 124 | 0.015 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.015 | |
| regulation of smoothened signaling pathway | GO:0008589 | 58 | 0.015 | |
| digestive tract morphogenesis | GO:0048546 | 147 | 0.015 | |
| auditory receptor cell fate specification | GO:0042667 | 1 | 0.015 | |
| regulation of cardioblast differentiation | GO:0051890 | 3 | 0.015 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.015 | |
| positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process | GO:2000763 | 1 | 0.015 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.015 | |
| catecholamine metabolic process | GO:0006584 | 30 | 0.015 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.015 | |
| nephrogenic mesenchyme development | GO:0072076 | 3 | 0.015 | |
| feeding behavior | GO:0007631 | 62 | 0.015 | |
| ribosomal small subunit assembly | GO:0000028 | 1 | 0.015 | |
| cardiac chamber development | GO:0003205 | 108 | 0.015 | |
| regulation of calcium ion transport | GO:0051924 | 69 | 0.015 | |
| gtp metabolic process | GO:0046039 | 144 | 0.015 | |
| plasma cell differentiation | GO:0002317 | 3 | 0.015 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.015 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.015 | |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.015 | |
| milk ejection | GO:0060156 | 1 | 0.015 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.015 | |
| axon guidance | GO:0007411 | 141 | 0.015 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.015 | |
| gastrin induced gastric acid secretion | GO:0001698 | 1 | 0.015 | |
| nuclear transport | GO:0051169 | 139 | 0.015 | |
| positive regulation of transcription by glucose | GO:0046016 | 3 | 0.015 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.015 | |
| synapse organization | GO:0050808 | 125 | 0.015 | |
| immunoglobulin production | GO:0002377 | 73 | 0.015 | |
| regulation of gliogenesis | GO:0014013 | 50 | 0.015 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.014 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.014 | |
| positive regulation of ossification | GO:0045778 | 47 | 0.014 | |
| face morphogenesis | GO:0060325 | 29 | 0.014 | |
| glucose metabolic process | GO:0006006 | 92 | 0.014 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.014 | |
| medial motor column neuron differentiation | GO:0021526 | 2 | 0.014 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.014 | |
| striated muscle cell proliferation | GO:0014855 | 39 | 0.014 | |
| regulation of anagen | GO:0051884 | 1 | 0.014 | |
| transmembrane transport | GO:0055085 | 412 | 0.014 | |
| cell migration in diencephalon | GO:0061381 | 1 | 0.014 | |
| renal capsule formation | GO:0072129 | 1 | 0.014 | |
| positive regulation of cell motility | GO:2000147 | 116 | 0.014 | |
| cation transport | GO:0006812 | 399 | 0.014 | |
| regulation of wnt signaling pathway | GO:0030111 | 123 | 0.014 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.014 | |
| ventricular cardiac myofibril assembly | GO:0055005 | 3 | 0.014 | |
| blastocyst development | GO:0001824 | 80 | 0.014 | |
| muscle tissue morphogenesis | GO:0060415 | 53 | 0.014 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.014 | |
| hippocampus development | GO:0021766 | 52 | 0.014 | |
| positive regulation of epithelial cell proliferation | GO:0050679 | 68 | 0.014 | |
